NEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced with great sadness the passing of longtime Board Member, William J. Kennedy, PhD. “It is with ...

William T. Clew, a respected journalist for decades ... In a 2018 interview, former T&G columnist Dianne Williamson said this about her mentor: “Bill Clew was both imposing and down to earth ...

Approved in February of 2021, TG Therapeutics’ first-in-class drug Ukoniq was billed as a potentially safer treatment for lymphoma patients. But 16 months later, the FDA has rescinded its ...